pathology_id stringlengths 19 19 | country stringclasses 7
values | year int64 2.02k 2.03k | facility_type stringclasses 3
values | cancer_type stringclasses 10
values | icd_o_morphology_code stringclasses 9
values | morphology_description stringclasses 9
values | grade stringclasses 4
values | lymphovascular_invasion stringclasses 3
values | perineural_invasion stringclasses 3
values | margin_status stringclasses 4
values | ihc_er stringclasses 3
values | ihc_pr stringclasses 3
values | ihc_her2 stringclasses 4
values | ihc_ki67_index stringclasses 825
values | ihc_p53 stringclasses 3
values | molecular_subtype stringclasses 4
values | specimen_type stringclasses 4
values | diagnosis_confirmed stringclasses 3
values | turnaround_time_days int64 3 27 | scenario stringclasses 1
value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PATH-TAN-2022-03901 | Tanzania | 2,022 | District | Colorectal | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Not documented | Not documented | Negative | Negative | Positive | Not done | Not done | Not done | null | Core needle biopsy | Yes | 16 | moderate_burden |
PATH-UGA-2019-03902 | Uganda | 2,019 | National referral | Prostate | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Present | Negative | Positive | Positive | Not done | 8.0 | Positive | null | Excisional biopsy | Yes | 11 | moderate_burden |
PATH-SOU-2022-03903 | South Africa | 2,022 | National referral | Prostate | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Present | Positive | Negative | Negative | Negative | 28.9 | Not done | null | Resection | Yes | 26 | moderate_burden |
PATH-SOU-2022-03904 | South Africa | 2,022 | District | Colorectal | 8260/3 | Papillary carcinoma | Moderately differentiated | Present | Not documented | Negative | Positive | Positive | Negative | Not done | Not done | null | Excisional biopsy | Yes | 4 | moderate_burden |
PATH-TAN-2018-03905 | Tanzania | 2,018 | District | Lung | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Close | Positive | Positive | Positive | 15.7 | Negative | null | Excisional biopsy | Yes | 18 | moderate_burden |
PATH-GHA-2023-03906 | Ghana | 2,023 | National referral | Colorectal | 8070/3 | Squamous cell carcinoma | Well differentiated | Absent | Absent | Negative | Negative | Negative | Negative | 43.1 | Positive | null | Resection | Yes | 13 | moderate_burden |
PATH-GHA-2023-03907 | Ghana | 2,023 | National referral | Colorectal | 8890/3 | Leiomyosarcoma | Undifferentiated | Absent | Absent | Close | Positive | Negative | Negative | 74.5 | Positive | null | Excisional biopsy | No - suboptimal | 21 | moderate_burden |
PATH-TAN-2021-03908 | Tanzania | 2,021 | Regional | Stomach | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Positive | Negative | Not done | Positive | null | Excisional biopsy | Yes | 27 | moderate_burden |
PATH-TAN-2019-03909 | Tanzania | 2,019 | District | Ovary | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Negative | Negative | Positive | Negative | Not done | Negative | null | Excisional biopsy | Yes | 12 | moderate_burden |
PATH-KEN-2019-03910 | Kenya | 2,019 | District | Lung | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Not documented | Negative | Not done | Positive | Not done | Not done | Positive | null | Excisional biopsy | Yes | 7 | moderate_burden |
PATH-SOU-2025-03911 | South Africa | 2,025 | District | Ovary | 8260/3 | Papillary carcinoma | Poorly differentiated | Absent | Absent | Not applicable | Positive | Not done | Positive | 89.9 | Not done | null | Resection | Yes | 14 | moderate_burden |
PATH-ETH-2023-03912 | Ethiopia | 2,023 | District | Prostate | 8140/3 | Adenocarcinoma | Well differentiated | Present | Present | Positive | Positive | Negative | Negative | Not done | Negative | null | Excisional biopsy | Yes | 12 | moderate_burden |
PATH-NIG-2019-03913 | Nigeria | 2,019 | Regional | Lung | 8260/3 | Papillary carcinoma | Moderately differentiated | Absent | Absent | Negative | Not done | Positive | Negative | 85.0 | Negative | null | Resection | Yes | 9 | moderate_burden |
PATH-NIG-2018-03914 | Nigeria | 2,018 | District | Lung | 8260/3 | Papillary carcinoma | Undifferentiated | Absent | Not documented | Positive | Negative | Positive | Positive | 27.8 | Negative | null | Excisional biopsy | Yes | 9 | moderate_burden |
PATH-NIG-2021-03915 | Nigeria | 2,021 | Regional | Liver | 8260/3 | Papillary carcinoma | Poorly differentiated | Present | Absent | Negative | Negative | Not done | Positive | Not done | Positive | null | Resection | Yes | 24 | moderate_burden |
PATH-UGA-2022-03916 | Uganda | 2,022 | National referral | Bladder | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Not done | Positive | Not done | 18.5 | Not done | null | Resection | Yes | 4 | moderate_burden |
PATH-TAN-2021-03917 | Tanzania | 2,021 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Present | Negative | Negative | Positive | Negative | 19.6 | Positive | null | Core needle biopsy | Yes | 8 | moderate_burden |
PATH-NIG-2019-03918 | Nigeria | 2,019 | National referral | Breast | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Present | Not applicable | Negative | Positive | Negative | 34.0 | Negative | Triple negative | Resection | Yes | 12 | moderate_burden |
PATH-ETH-2019-03919 | Ethiopia | 2,019 | National referral | Lung | 8260/3 | Papillary carcinoma | Poorly differentiated | Absent | Absent | Close | Negative | Negative | Negative | 37.5 | Negative | null | Core needle biopsy | Yes | 10 | moderate_burden |
PATH-UGA-2022-03920 | Uganda | 2,022 | District | Ovary | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Not documented | Negative | Positive | Negative | Positive | Not done | Negative | null | Resection | Yes | 8 | moderate_burden |
PATH-KEN-2021-03921 | Kenya | 2,021 | Regional | Thyroid | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Not done | Equivocal | 37.1 | Negative | null | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-UGA-2022-03922 | Uganda | 2,022 | Regional | Thyroid | 8510/3 | Medullary carcinoma | Well differentiated | Absent | Absent | Positive | Positive | Positive | Positive | 24.6 | Negative | null | Core needle biopsy | No - inconclusive | 15 | moderate_burden |
PATH-SOU-2021-03923 | South Africa | 2,021 | Regional | Breast | 8500/3 | Ductal carcinoma | Well differentiated | Present | Not documented | Positive | Positive | Positive | Negative | 9.7 | Positive | Luminal B | Excisional biopsy | Yes | 5 | moderate_burden |
PATH-ETH-2021-03924 | Ethiopia | 2,021 | District | Prostate | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Negative | Negative | 90.0 | Positive | null | Excisional biopsy | No - inconclusive | 15 | moderate_burden |
PATH-ETH-2019-03925 | Ethiopia | 2,019 | National referral | Liver | 8070/3 | Squamous cell carcinoma | Undifferentiated | Present | Absent | Negative | Positive | Positive | Negative | 58.9 | Negative | null | Core needle biopsy | Yes | 21 | moderate_burden |
PATH-NIG-2022-03926 | Nigeria | 2,022 | Regional | Lung | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Absent | Negative | Negative | Negative | Negative | Not done | Negative | null | Resection | Yes | 15 | moderate_burden |
PATH-UGA-2024-03927 | Uganda | 2,024 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Close | Positive | Positive | Negative | 44.2 | Negative | null | Core needle biopsy | Yes | 21 | moderate_burden |
PATH-UGA-2019-03928 | Uganda | 2,019 | Regional | Lung | 8500/3 | Ductal carcinoma | Undifferentiated | Not documented | Absent | Not applicable | Positive | Negative | Positive | Not done | Not done | null | Core needle biopsy | Yes | 9 | moderate_burden |
PATH-ETH-2022-03929 | Ethiopia | 2,022 | National referral | Breast | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Close | Positive | Positive | Negative | 13.3 | Not done | Luminal B | Resection | Yes | 14 | moderate_burden |
PATH-KEN-2020-03930 | Kenya | 2,020 | District | Stomach | 8070/3 | Squamous cell carcinoma | Well differentiated | Absent | Not documented | Negative | Positive | Negative | Negative | 46.3 | Positive | null | Excisional biopsy | Yes | 24 | moderate_burden |
PATH-KEN-2019-03931 | Kenya | 2,019 | National referral | Bladder | 8310/3 | Clear cell carcinoma | Moderately differentiated | Absent | Present | Negative | Positive | Negative | Positive | 78.8 | Negative | null | Resection | Yes | 6 | moderate_burden |
PATH-ETH-2025-03932 | Ethiopia | 2,025 | National referral | Liver | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Not documented | Positive | Positive | Not done | Negative | 78.6 | Negative | null | Core needle biopsy | Yes | 25 | moderate_burden |
PATH-SOU-2024-03933 | South Africa | 2,024 | District | Colorectal | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Absent | Not applicable | Positive | Negative | Negative | Not done | Negative | null | Core needle biopsy | No - inconclusive | 10 | moderate_burden |
PATH-ETH-2021-03934 | Ethiopia | 2,021 | Regional | Prostate | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Absent | Close | Negative | Positive | Not done | 39.2 | Negative | null | Core needle biopsy | Yes | 11 | moderate_burden |
PATH-ETH-2018-03935 | Ethiopia | 2,018 | Regional | Prostate | 8430/3 | Mucoepidermoid carcinoma | Moderately differentiated | Not documented | Not documented | Negative | Negative | Positive | Negative | 84.2 | Negative | null | Excisional biopsy | Yes | 8 | moderate_burden |
PATH-ETH-2019-03936 | Ethiopia | 2,019 | District | Liver | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Present | Negative | Negative | Positive | Negative | Not done | Positive | null | Fine needle aspirate | Yes | 24 | moderate_burden |
PATH-KEN-2023-03937 | Kenya | 2,023 | Regional | Prostate | 8260/3 | Papillary carcinoma | Poorly differentiated | Present | Present | Negative | Negative | Positive | Negative | Not done | Not done | null | Excisional biopsy | Yes | 16 | moderate_burden |
PATH-NIG-2025-03938 | Nigeria | 2,025 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Negative | Not done | Not done | Negative | 87.3 | Negative | null | Core needle biopsy | Yes | 16 | moderate_burden |
PATH-GHA-2019-03939 | Ghana | 2,019 | National referral | Prostate | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Present | Negative | Positive | Not done | Negative | 83.4 | Not done | null | Resection | No - suboptimal | 16 | moderate_burden |
PATH-GHA-2018-03940 | Ghana | 2,018 | District | Stomach | 8140/3 | Adenocarcinoma | Undifferentiated | Not documented | Absent | Close | Not done | Negative | Not done | Not done | Positive | null | Resection | Yes | 10 | moderate_burden |
PATH-KEN-2020-03941 | Kenya | 2,020 | Regional | Prostate | 8510/3 | Medullary carcinoma | Moderately differentiated | Present | Not documented | Negative | Negative | Negative | Negative | Not done | Positive | null | Resection | Yes | 5 | moderate_burden |
PATH-NIG-2022-03942 | Nigeria | 2,022 | District | Bladder | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Not documented | Absent | Negative | Not done | Negative | Negative | Not done | Positive | null | Fine needle aspirate | Yes | 26 | moderate_burden |
PATH-ETH-2019-03943 | Ethiopia | 2,019 | National referral | Prostate | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Not documented | Negative | Not done | Negative | Negative | 61.4 | Positive | null | Core needle biopsy | Yes | 4 | moderate_burden |
PATH-KEN-2023-03944 | Kenya | 2,023 | District | Ovary | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Negative | Negative | 45.4 | Negative | null | Core needle biopsy | Yes | 24 | moderate_burden |
PATH-ETH-2024-03945 | Ethiopia | 2,024 | District | Stomach | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Present | Close | Not done | Negative | Negative | Not done | Positive | null | Core needle biopsy | Yes | 24 | moderate_burden |
PATH-SOU-2023-03946 | South Africa | 2,023 | District | Colorectal | 8260/3 | Papillary carcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Positive | Positive | Not done | Negative | null | Core needle biopsy | Yes | 9 | moderate_burden |
PATH-NIG-2025-03947 | Nigeria | 2,025 | National referral | Cervix | 8510/3 | Medullary carcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Positive | Equivocal | Not done | Positive | null | Resection | Yes | 9 | moderate_burden |
PATH-NIG-2020-03948 | Nigeria | 2,020 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Close | Not done | Not done | Equivocal | 75.1 | Negative | null | Excisional biopsy | Yes | 9 | moderate_burden |
PATH-ETH-2020-03949 | Ethiopia | 2,020 | District | Ovary | 8890/3 | Leiomyosarcoma | Poorly differentiated | Not documented | Not documented | Negative | Positive | Positive | Negative | 13.6 | Negative | null | Core needle biopsy | No - suboptimal | 10 | moderate_burden |
PATH-SOU-2020-03950 | South Africa | 2,020 | Regional | Prostate | 8260/3 | Papillary carcinoma | Well differentiated | Absent | Not documented | Close | Positive | Negative | Equivocal | 65.8 | Positive | null | Core needle biopsy | Yes | 23 | moderate_burden |
PATH-SOU-2019-03951 | South Africa | 2,019 | National referral | Ovary | 8890/3 | Leiomyosarcoma | Well differentiated | Present | Not documented | Negative | Positive | Negative | Negative | 42.7 | Positive | null | Fine needle aspirate | Yes | 20 | moderate_burden |
PATH-GHA-2024-03952 | Ghana | 2,024 | Regional | Breast | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Not documented | Negative | Negative | Not done | Negative | 66.1 | Negative | Triple negative | Excisional biopsy | Yes | 13 | moderate_burden |
PATH-UGA-2024-03953 | Uganda | 2,024 | District | Prostate | 8260/3 | Papillary carcinoma | Well differentiated | Absent | Absent | Negative | Negative | Positive | Negative | 58.0 | Positive | null | Core needle biopsy | Yes | 5 | moderate_burden |
PATH-UGA-2019-03954 | Uganda | 2,019 | Regional | Liver | 8310/3 | Clear cell carcinoma | Poorly differentiated | Absent | Absent | Positive | Negative | Negative | Negative | 11.0 | Negative | null | Core needle biopsy | No - inconclusive | 22 | moderate_burden |
PATH-SOU-2021-03955 | South Africa | 2,021 | District | Colorectal | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Positive | Negative | Positive | Negative | 53.2 | Negative | null | Fine needle aspirate | Yes | 20 | moderate_burden |
PATH-GHA-2021-03956 | Ghana | 2,021 | National referral | Prostate | 8500/3 | Ductal carcinoma | Well differentiated | Absent | Absent | Negative | Positive | Positive | Not done | 50.3 | Positive | null | Resection | Yes | 4 | moderate_burden |
PATH-KEN-2018-03957 | Kenya | 2,018 | District | Liver | 8430/3 | Mucoepidermoid carcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Not done | Negative | 71.6 | Negative | null | Core needle biopsy | Yes | 25 | moderate_burden |
PATH-NIG-2022-03958 | Nigeria | 2,022 | District | Stomach | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Present | Not applicable | Positive | Negative | Positive | 42.3 | Positive | null | Core needle biopsy | Yes | 21 | moderate_burden |
PATH-NIG-2023-03959 | Nigeria | 2,023 | National referral | Breast | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Absent | Not applicable | Positive | Negative | Positive | 87.1 | Positive | Luminal A | Resection | Yes | 7 | moderate_burden |
PATH-SOU-2022-03960 | South Africa | 2,022 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Not applicable | Positive | Negative | Negative | 76.0 | Positive | null | Core needle biopsy | Yes | 26 | moderate_burden |
PATH-NIG-2023-03961 | Nigeria | 2,023 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Moderately differentiated | Not documented | Absent | Negative | Positive | Not done | Negative | 20.9 | Negative | null | Core needle biopsy | Yes | 5 | moderate_burden |
PATH-GHA-2025-03962 | Ghana | 2,025 | National referral | Bladder | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Not documented | Not documented | Negative | Positive | Positive | Equivocal | 18.6 | Positive | null | Excisional biopsy | Yes | 5 | moderate_burden |
PATH-TAN-2022-03963 | Tanzania | 2,022 | District | Colorectal | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Negative | Positive | Negative | Negative | Not done | Negative | null | Excisional biopsy | Yes | 19 | moderate_burden |
PATH-NIG-2023-03964 | Nigeria | 2,023 | National referral | Bladder | 8510/3 | Medullary carcinoma | Undifferentiated | Absent | Not documented | Negative | Positive | Negative | Negative | 86.7 | Not done | null | Excisional biopsy | Yes | 25 | moderate_burden |
PATH-TAN-2020-03965 | Tanzania | 2,020 | Regional | Ovary | 8260/3 | Papillary carcinoma | Well differentiated | Absent | Not documented | Negative | Not done | Negative | Negative | Not done | Positive | null | Excisional biopsy | Yes | 23 | moderate_burden |
PATH-TAN-2021-03966 | Tanzania | 2,021 | Regional | Stomach | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Positive | Not done | 5.6 | Negative | null | Fine needle aspirate | No - inconclusive | 24 | moderate_burden |
PATH-NIG-2022-03967 | Nigeria | 2,022 | District | Prostate | 8260/3 | Papillary carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Positive | Not done | Not done | Positive | null | Excisional biopsy | No - inconclusive | 7 | moderate_burden |
PATH-NIG-2018-03968 | Nigeria | 2,018 | Regional | Stomach | 8510/3 | Medullary carcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Negative | Negative | 84.6 | Positive | null | Excisional biopsy | Yes | 4 | moderate_burden |
PATH-TAN-2021-03969 | Tanzania | 2,021 | Regional | Lung | 8510/3 | Medullary carcinoma | Poorly differentiated | Absent | Not documented | Close | Negative | Negative | Negative | 61.9 | Not done | null | Resection | Yes | 23 | moderate_burden |
PATH-NIG-2019-03970 | Nigeria | 2,019 | Regional | Liver | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Absent | Negative | Negative | Positive | Negative | Not done | Negative | null | Core needle biopsy | Yes | 20 | moderate_burden |
PATH-NIG-2022-03971 | Nigeria | 2,022 | Regional | Liver | 8260/3 | Papillary carcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Negative | Not done | 15.4 | Not done | null | Core needle biopsy | Yes | 22 | moderate_burden |
PATH-UGA-2025-03972 | Uganda | 2,025 | National referral | Liver | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Not documented | Positive | Positive | Positive | Negative | 51.5 | Negative | null | Resection | Yes | 23 | moderate_burden |
PATH-TAN-2023-03973 | Tanzania | 2,023 | National referral | Stomach | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Absent | Negative | Negative | Positive | Positive | 69.5 | Negative | null | Resection | Yes | 27 | moderate_burden |
PATH-NIG-2018-03974 | Nigeria | 2,018 | District | Breast | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Not documented | Absent | Negative | Positive | Positive | Negative | Not done | Positive | Triple negative | Resection | Yes | 8 | moderate_burden |
PATH-TAN-2021-03975 | Tanzania | 2,021 | District | Breast | 8140/3 | Adenocarcinoma | Well differentiated | Present | Not documented | Negative | Negative | Negative | Negative | Not done | Negative | Luminal A | Resection | Yes | 19 | moderate_burden |
PATH-KEN-2025-03976 | Kenya | 2,025 | Regional | Prostate | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Present | Negative | Negative | Not done | Negative | 13.4 | Positive | null | Core needle biopsy | Yes | 13 | moderate_burden |
PATH-GHA-2023-03977 | Ghana | 2,023 | District | Lung | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Not documented | Close | Positive | Negative | Not done | 27.0 | Positive | null | Excisional biopsy | Yes | 24 | moderate_burden |
PATH-UGA-2022-03978 | Uganda | 2,022 | Regional | Bladder | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Present | Negative | Positive | Negative | Negative | 29.9 | Negative | null | Core needle biopsy | Yes | 25 | moderate_burden |
PATH-SOU-2019-03979 | South Africa | 2,019 | National referral | Ovary | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Not documented | Positive | Positive | Negative | Negative | 28.4 | Negative | null | Excisional biopsy | Yes | 27 | moderate_burden |
PATH-KEN-2020-03980 | Kenya | 2,020 | Regional | Stomach | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Not documented | Negative | Positive | Negative | Negative | 45.7 | Negative | null | Core needle biopsy | Yes | 4 | moderate_burden |
PATH-NIG-2023-03981 | Nigeria | 2,023 | District | Ovary | 8510/3 | Medullary carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Positive | Negative | 87.8 | Positive | null | Core needle biopsy | Yes | 9 | moderate_burden |
PATH-NIG-2021-03982 | Nigeria | 2,021 | District | Breast | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Absent | Negative | Not done | Positive | Negative | 36.4 | Positive | Luminal A | Core needle biopsy | Yes | 7 | moderate_burden |
PATH-GHA-2018-03983 | Ghana | 2,018 | National referral | Colorectal | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Positive | Positive | Positive | Negative | 9.9 | Positive | null | Core needle biopsy | Yes | 9 | moderate_burden |
PATH-TAN-2022-03984 | Tanzania | 2,022 | Regional | Prostate | 8500/3 | Ductal carcinoma | Well differentiated | Absent | Absent | Close | Negative | Negative | Not done | 30.5 | Negative | null | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-SOU-2023-03985 | South Africa | 2,023 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Not documented | Negative | Positive | Negative | Negative | 89.6 | Not done | null | Resection | Yes | 7 | moderate_burden |
PATH-GHA-2025-03986 | Ghana | 2,025 | Regional | Colorectal | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Not documented | Negative | Positive | Positive | Not done | 57.5 | Negative | null | Core needle biopsy | Yes | 14 | moderate_burden |
PATH-KEN-2024-03987 | Kenya | 2,024 | National referral | Stomach | 8310/3 | Clear cell carcinoma | Moderately differentiated | Absent | Present | Negative | Positive | Positive | Negative | 30.2 | Positive | null | Resection | No - inconclusive | 20 | moderate_burden |
PATH-SOU-2022-03988 | South Africa | 2,022 | Regional | Colorectal | 8310/3 | Clear cell carcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Positive | Negative | 66.2 | Negative | null | Fine needle aspirate | Yes | 26 | moderate_burden |
PATH-KEN-2019-03989 | Kenya | 2,019 | District | Bladder | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Present | Negative | Not done | Negative | Negative | Not done | Positive | null | Core needle biopsy | Yes | 20 | moderate_burden |
PATH-TAN-2018-03990 | Tanzania | 2,018 | National referral | Liver | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Not done | Negative | Not done | 69.8 | Not done | null | Excisional biopsy | Yes | 27 | moderate_burden |
PATH-SOU-2024-03991 | South Africa | 2,024 | Regional | Breast | 8140/3 | Adenocarcinoma | Undifferentiated | Present | Present | Negative | Positive | Positive | Negative | Not done | Negative | null | Core needle biopsy | No - inconclusive | 21 | moderate_burden |
PATH-ETH-2018-03992 | Ethiopia | 2,018 | Regional | Cervix | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Not documented | Not applicable | Negative | Negative | Negative | 58.1 | Negative | null | Excisional biopsy | Yes | 22 | moderate_burden |
PATH-ETH-2020-03993 | Ethiopia | 2,020 | District | Prostate | 8510/3 | Medullary carcinoma | Poorly differentiated | Not documented | Absent | Positive | Positive | Positive | Negative | 41.1 | Not done | null | Core needle biopsy | Yes | 12 | moderate_burden |
PATH-TAN-2022-03994 | Tanzania | 2,022 | National referral | Prostate | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Not documented | Absent | Negative | Positive | Negative | Negative | 44.7 | Negative | null | Core needle biopsy | Yes | 10 | moderate_burden |
PATH-GHA-2019-03995 | Ghana | 2,019 | Regional | Prostate | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Not documented | Absent | Negative | Negative | Negative | Negative | 45.6 | Positive | null | Resection | Yes | 13 | moderate_burden |
PATH-GHA-2018-03996 | Ghana | 2,018 | District | Colorectal | 8720/3 | Melanoma | Moderately differentiated | Absent | Present | Negative | Positive | Negative | Negative | 69.5 | Positive | null | Core needle biopsy | Yes | 20 | moderate_burden |
PATH-NIG-2021-03997 | Nigeria | 2,021 | District | Cervix | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Absent | Close | Positive | Positive | Negative | 47.1 | Negative | null | Core needle biopsy | Yes | 14 | moderate_burden |
PATH-SOU-2020-03998 | South Africa | 2,020 | Regional | Breast | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Present | Negative | Positive | Positive | Negative | 35.3 | Positive | Luminal A | Resection | Yes | 14 | moderate_burden |
PATH-TAN-2019-03999 | Tanzania | 2,019 | Regional | Prostate | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Not documented | Positive | Positive | Negative | Negative | Not done | Positive | null | Resection | Yes | 22 | moderate_burden |
PATH-UGA-2019-04000 | Uganda | 2,019 | Regional | Breast | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Absent | Close | Negative | Negative | Negative | 70.2 | Negative | Luminal B | Fine needle aspirate | Yes | 12 | moderate_burden |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.